probiotics
Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.
Industry
Two pioneering companies are poised to explore the genetic frontiers of probiotic bacteria, seeking out strains that can produce sustainable quantities of life-enhancing microbial metabolites.
Events
Alessio Fasano gives an overview of the IHMC Congress to be held in Rome, 22-25 June.
Join SynBalance, platinum sponsor at Probiota Global 2024 (7-9 February, Milan), and discover the newst scientific data on ProBeautyShield, the probiotic ingredient designed for skin health.
Gastroenterology
The findings of a recent study suggest that a mixture of B. infantis and HMOs can modulate the gut microbiota in adults.
Industry
In a significant move to expand its immuno-oncology portfolio, Boehringer Ingelheim has acquired T3 Pharmaceuticals AG, a Swiss biotech company specializing in bacterial cancer therapy.
Industry
Epatrex, a new nutraceutical compound formulated as a three-layer tablet containing the probiotic Lactobacillus casei LC-XCAL.
Industry
The therapy, combining human milk oligosaccharides (HMOs) and a specific gut bacteria strain, represents not only a scientific breakthrough but also holds substantial economic implications.
Smiling ear to ear, supporting healthy teeth and mouth.
This approval marks a significant leap forward in our understanding of holistic health and the intricate connection between our guts and our brains.